Valuation: MINAPHARM Pharmaceuticals

Market Cap 910.76Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.57TCr 25Cr 172.89Cr 69Cr 856.07Cr 64Cr 62Cr 2.69TCr P/E 2024
14x
P/E 2025 584x
Enterprise Value 1.02TCr 19Cr 17Cr 16Cr 14Cr 27Cr 1.76TCr 29Cr 193.96Cr 77Cr 960.42Cr 71Cr 70Cr 3.01TCr EV / Sales 2024
0.78x
EV / Sales 2025 0.81x
Free-Float
15.13%
Yield 2024
1.54%
Yield 2025 -
1 day-0.88%
1 week-2.47%
Current month+3.07%
1 month+3.34%
3 months-2.17%
6 months+18.85%
Current year+121.39%
1 week 748
Extreme 748
820
1 month 610
Extreme 610
820
Current year 320.23
Extreme 320.23
1,000
1 year 303.1
Extreme 303.1
1,000
3 years 145
Extreme 145
1,000
5 years 101.11
Extreme 101.11
1,000
10 years 45
Extreme 45
1,000
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - 19/10/2010
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - 18/10/2010
Director/Board Member - 18/10/2010
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%-2.47%+141.98%+225.45% 17Cr
-0.30%-6.68%+27.12%+127.32% 1,20000Cr
+1.25%-5.35%+32.65%+78.98% 65TCr
+0.94%-2.99%+21.13%+106.30% 51TCr
-0.60%-1.95%+25.73%+67.00% 38TCr
+0.69%-9.50%+36.78%+30.83% 33TCr
+0.41%-4.70%+24.18%+50.18% 29TCr
+0.81%-4.08%-2.95%+31.59% 27TCr
-0.15%-6.45%+29.06%+65.76% 24TCr
-0.06%-0.98%+31.42%+122.83% 21TCr
Average +0.21%-4.34%+36.71%+90.62% 41TCr
Weighted average by Cap. +0.30%-5.19%+26.03%+87.88%

Financials

2024 2025
Net sales 566.48Cr 11Cr 9.59Cr 8.84Cr 8.04Cr 15Cr 974.86Cr 16Cr 107.53Cr 43Cr 532.46Cr 39Cr 39Cr 1.67TCr 643.82Cr 12Cr 11Cr 10Cr 9.13Cr 17Cr 1.11TCr 18Cr 122.21Cr 49Cr 605.16Cr 45Cr 44Cr 1.9TCr
Net income 16Cr 29.19L 26.59L 24.5L 22.28L 41.81L 27Cr 43.94L 2.98Cr 1.19Cr 15Cr 1.1Cr 1.07Cr 46Cr 4.02Cr 7L 7L 6L 6L 10.7L 6.92Cr 11.25L 76.34L 30.34L 3.78Cr 28.04L 27.45L 12Cr
Net Debt 259.82Cr 4.83Cr 4.4Cr 4.05Cr 3.69Cr 6.92Cr 447.12Cr 7.27Cr 49Cr 20Cr 244.22Cr 18Cr 18Cr 766.45Cr 111.01Cr 2.06Cr 1.88Cr 1.73Cr 1.57Cr 2.95Cr 191.04Cr 3.11Cr 21Cr 8.38Cr 104.35Cr 7.74Cr 7.58Cr 327.48Cr
Projected Income Statement - Annual - MINAPHARM Pharmaceuticals
Logo MINAPHARM Pharmaceuticals
Minapharm Pharmaceuticals S.A.E. specializes in developing, manufacturing and marketing prescription pharmaceutical products. The products are for the treatment of gastroenterological, ophthalmologic, cardiovascular, genetic, dermatological, orthopedic diseases, etc.
Employees
-
Date Price Change Volume
19/26/19 EGP 773.08 -0.88% 925
18/26/18 EGP 779.92 -2.43% 1,124
17/26/17 EGP 799.36 +5.16% 6,791
16/26/16 EGP 760.14 -2.30% 2,187
15/26/15 EGP 778.05 -1.85% 9,212
  1. Stock Market
  2. Stocks
  3. MIPH Stock